A study shows significant association between MTHFR C677T polymorphisms and risk of oral squamous cell carcinoma.
MRI-guided laser interstitial thermal therapy appears to be safe and effective for glioblastomas and may add an average of 2 months to life expectancy.
Outcomes for patients with HER2-positive breast cancer did not differ when treated with sequential chemotherapy plus trastuzumab compared with a concurrent approach.
ZHX2 has been identified as a possible new therapeutic target for clear cell RCC patients.
How much do you know about the genomics of multiple myeloma? Take our latest quiz to sharpen your knowledge.
Recent studies on CAR T-cell immunotherapy, and the recent approval of a new agent, add to evidence supporting the efficacy of these therapies.
A 17-gene signature derived from circulating tumor cells was found to correlate with response to therapy in patients with breast cancer.
The combination of pembrolizumab and a TLR9 agonist known as SD-101 showed promising activity in patients with unresectable or metastatic melanoma.
The number of nurse practitioners and physician assistants in oncology is growing, according to a new study.
A study shows bendamustine followed by venetoclax and obinutuzumab was active in treatment-naive or relapsed/refractory CLL.
Ibrutinib demonstrated superior response rates and survival in certain CLL patients despite exclusion from major clinical trials.
Cross-sectional, long-term imaging is shown to be important for patients with high-risk resected non–clear cell RCC.
Concentrations of KIM-1 in the blood may predict for renal cell carcinoma up to 5 years prior to diagnosis.
A patient with a history of thalassemia minor presents with chest pain and a cough. Imaging shows a posterior mediastinal mass. A biopsy is performed. What is your diagnosis?
A meta-analysis finds that postmenopausal bleeding occurs in approximately 90% of women with endometrial cancer.